BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $125,572,000 | +3.7% | 830,668 | -0.0% | 0.13% | +12.4% |
| Q2 2022 | $121,052,000 | -11.4% | 830,776 | -27.9% | 0.11% | +9.7% |
| Q1 2022 | $136,572,000 | +13.6% | 1,151,829 | +32.0% | 0.10% | +25.6% |
| Q4 2021 | $120,249,000 | -0.7% | 872,570 | +0.1% | 0.08% | -4.7% |
| Q3 2021 | $121,098,000 | +42.7% | 871,776 | -0.3% | 0.09% | +45.8% |
| Q2 2021 | $84,878,000 | +64.0% | 874,314 | +15.4% | 0.06% | +51.3% |
| Q1 2021 | $51,764,000 | +13.2% | 757,340 | +41.9% | 0.04% | +11.4% |
| Q4 2020 | $45,738,000 | +90.6% | 533,631 | +44.6% | 0.04% | +66.7% |
| Q3 2020 | $23,999,000 | +17.5% | 369,156 | +32.2% | 0.02% | +16.7% |
| Q2 2020 | $20,423,000 | – | 279,345 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |